Talk Patient Engagement and Recruitment track
Addressing Clinical Trial Diversity in a Global Context: Challenges, Opportunities, and Critical Capabilities
Tue, Oct 29, 2024 · 4:32–4:57 PM CET InterContinental Barcelona
About this session
Session: ADVANCING INCLUSIVE RESEARCH: DIVERSITY PLANNING, COMMUNITY ENGAGEMENT & SITE ENABLEMENT
The FDA has led the charge with its recently updated draft guidance. As sponsors of global studies, ensuring that patients in our studies reflect those who may use the medicine requires capabilities that go beyond the U.S. FDA requirements. We will share our experience in building enterprise-level capabilities to improve diversity through design, planning, execution, and monitoring, in line with AstraZeneca's global diversity ambition.
Speaker
-
Senior Director, Clinical Trial Diversity · AstraZeneca
Speaker